
Ch55
CAS No. 110368-33-7
Ch55 ( CH 55 | Ch-55 | 3,5-Di-tert-butylchalcone )
产品货号. M26646 CAS No. 110368-33-7
Ch55 是 HL60 细胞分化的有效诱导剂 (EC50 = 200 nM),并且与 RAR-α 和 RAR-β 受体具有高亲和力。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥786 | 有现货 |
![]() ![]() |
10MG | ¥1191 | 有现货 |
![]() ![]() |
25MG | ¥2317 | 有现货 |
![]() ![]() |
50MG | ¥4228 | 有现货 |
![]() ![]() |
100MG | ¥6148 | 有现货 |
![]() ![]() |
500MG | ¥12798 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Ch55
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Ch55 是 HL60 细胞分化的有效诱导剂 (EC50 = 200 nM),并且与 RAR-α 和 RAR-β 受体具有高亲和力。
-
产品描述Ch55 is an effective inducer of the differentiation of HL60 cells (EC50 = 200 nM) and shows high affinity with RAR-α and RAR-β receptors. Ch55 can be used in studies about cancer.(In Vitro):In rabbit tracheal epithelial cells, Ch55 inhibits type I transglutaminase activity (EC50 = 0.02 nM) and increases cholesterol sulfate levels (EC50 = 0.03 nM) thereby inhibiting squamous cell differentiation. Ch55 inhibits the induction of ornithine decarboxylase activity in 3T6 fibroblasts (EC50 = 1 nM) and induces cell differentiation of embryonic carcinoma F9 cells and melanoma S91 cells (EC50 = 0.26 and 0.5 nM). Ch55 shows a low affinity for cellular retinoic acid binding protein.
-
体外实验——
-
体内实验——
-
同义词CH 55 | Ch-55 | 3,5-Di-tert-butylchalcone
-
通路Metabolic Enzyme/Protease
-
靶点Retinoid Receptor
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number110368-33-7
-
分子量364.48
-
分子式C24H28O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 50 mg/mL (137.18 mM)
-
SMILESCC(C)(C)c1cc(cc(c1)C(C)(C)C)C(=O)\C=C\c1ccc(cc1)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Shi J, et al. Sacubitril Is Selectively Activated by Carboxylesterase 1 (CES1) in the Liver and the Activation Is Affected by CES1 Genetic Variation. Drug Metab Dispos. 2016 Apr;44(4):554-9.
产品手册




关联产品
-
Tamibarotene
他米巴罗汀是一种合成的视黄酸受体 (RAR) 激动剂,对 RARα 和 RARβ 的特异性高于 RARγ。
-
K-8012
K-8012 is a modulator of the N-terminally truncated RXRα and improves anticancer activities in an RXRα-dependent manner.
-
BMS 195614
BMS 195614 (BMS614) is a selective RARα antagonist. BMS 195614 can bind to the RARα subunit.